9780132344494-0132344491-Reasonable RX: Solving the Drug Price Crisis

Reasonable RX: Solving the Drug Price Crisis

ISBN-13: 9780132344494
ISBN-10: 0132344491
Edition: 1
Author: Stan Finkelstein, Professor of Economics Peter Temin
Publication date: 2008
Publisher: FT Press
Format: Hardcover 188 pages
FREE US shipping
Buy

From $23.79

Book details

ISBN-13: 9780132344494
ISBN-10: 0132344491
Edition: 1
Author: Stan Finkelstein, Professor of Economics Peter Temin
Publication date: 2008
Publisher: FT Press
Format: Hardcover 188 pages

Summary

Reasonable RX: Solving the Drug Price Crisis (ISBN-13: 9780132344494 and ISBN-10: 0132344491), written by authors Stan Finkelstein, Professor of Economics Peter Temin, was published by FT Press in 2008. With an overall rating of 4.2 stars, it's a notable title among other books. You can easily purchase or rent Reasonable RX: Solving the Drug Price Crisis (Hardcover) from BooksRun, along with many other new and used books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.3.

Description

A Real Plan for Making Drugs Affordable–and Promoting Innovation, Too

“This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making.”

–Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University

“This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all–and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially.”

–Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former

senior official of the Food and Drug Administration

“This book confounds two sets of skeptics: Those who say there’s no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say.”

–Honorable Barney Frank, Congressman from Massachusetts

“This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a must for insiders of the pharma- and biotech industries.”

–Dr. Jürgen Drews, retired President of Roche Pharmaceutical Group Global Research

Acknowledgments viii

About the Authors ix

Introduction xi

Chapter 1: Drugs and Drug Prices 1

Chapter 2: The American Way to Discover Drugs 21

Chapter 3: The Drug Industry Today 39

Chapter 4: Are Drug Companies Risky? 59

Chapter 5: How Not to Lower Drug Prices 77

Chapter 6: Squandering R & D Resources 103

Chapter 7: How to Lower Drug Prices 129

Appendix: Our Solution in Detail 155


Index 177

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book